Voice recognition software developer Nuance has cut a deal to acquire Dictaphone. Nuance executives say they expect the all-cash $357 million agreement to accelerate the adoption of voice recognition as a replacement for manual transcription.
Voice recognition software developer Nuance has cut a deal to acquire Dictaphone. Nuance executives say they expect the all-cash $357 million agreement to accelerate the adoption of voice recognition as a replacement for manual transcription.
"It is our goal by the end of this decade to replace most manual transcription in healthcare with speech-enabled automated solutions, giving care providers and medical transcription services the ability to reduce manual transcription costs by over $5 billion a year," said Paul Ricci, chairman and CEO of Nuance.
U.S. medical providers spend about $10 billion annually to transcribe spoken reports, according to Ricci.
The deal to merge Dictaphone and Nuance is expected to close March 31, pending regulatory approvals and due diligence. If it does, Dictaphone will operate as a wholly owned subsidiary of Nuance.
Editor's Note: What the merger will mean for Nuance, Dictaphone, and the medical community at large will be featured in the Feb. 20 issue of SCAN.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.